Novel injectables are newly marketed biological products, such as exosomes, amniotic products and protein concentrates, that reach athletes faster than evidence or regulation can follow.
An athlete will usually hear about one before the clinician does. Rather than a catalogue that will date, this page sets out a method for assessing any unfamiliar injectable and applies it to the categories currently marketed.
Platelet-rich plasma and the general orthobiologics regulatory framework have their own pages. This one concentrates on what is genuinely new, what is simply relabelled, and how to answer the athlete who arrives with a brochure.
Unlock 10 full topics of your choice with a free account.
Already have an account? Log in